Georgia Tech Releases Machine Learning Software to Further Cancer Drug Research

HealthTech focuses on the recent news that School of Biological Sciences researchers are allowing all scientists to use their new machine learning software for predicting cancer drug effectiveness. The hope is that the open source software approach, which will crowdsource research brainpower and expertise, will speed up the clinical trials process for cancer drug approval. Assistant Professor Fredrik Vannberg and Professor John McDonald contributed to the research; McDonald is also director of Tech's Integrated Cancer Research Center.

Author: 
Renay San Miguel